China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency
China Resources Boya Bio pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥36.82 Million ≈ $5.39 Million USD) by net assets (CN¥7.46 Billion ≈ $1.09 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Cash flow conversion efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. This chart illustrates how China Resources Boya Bio pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300294 live share price for real-time trading data and today's change.
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained
China Resources Boya Bio pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Resources Boya Bio pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 300294 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corbion N.V.
F:CSU
|
0.038x |
|
Shenzhen Clou Electronics Co Ltd
SHE:002121
|
0.146x |
|
Anhui Water Resources Development Co Ltd
SHG:600502
|
0.018x |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
0.026x |
|
ShenZhen Kondarl Group Co Ltd
SHE:000048
|
0.061x |
|
ZINKA LOGISTICS SOL LTD
NSE:BLACKBUCK
|
0.092x |
|
Chengdu Gas Group Co Ltd
SHG:603053
|
-0.008x |
|
Shinyoung HappyTomorrow No.5 Special Purpose Acquisition Company
KQ:323280
|
-0.079x |
Annual Cash Flow Conversion Efficiency for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
The table below shows the annual cash flow conversion efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2025. Review China Resources Boya Bio pharmaceutical free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
CN¥116.69 Million ≈ $17.07 Million |
0.016x | -60.96% |
| 2024-12-31 | CN¥7.49 Billion ≈ $1.10 Billion |
CN¥299.78 Million ≈ $43.87 Million |
0.040x | -54.33% |
| 2023-12-31 | CN¥7.32 Billion ≈ $1.07 Billion |
CN¥641.73 Million ≈ $93.90 Million |
0.088x | +7.06% |
| 2022-12-31 | CN¥7.28 Billion ≈ $1.07 Billion |
CN¥596.44 Million ≈ $87.28 Million |
0.082x | -57.88% |
| 2021-12-31 | CN¥6.92 Billion ≈ $1.01 Billion |
CN¥1.35 Billion ≈ $196.87 Million |
0.194x | +13.42% |
| 2020-12-31 | CN¥4.19 Billion ≈ $613.49 Million |
CN¥718.58 Million ≈ $105.15 Million |
0.171x | +697.00% |
| 2019-12-31 | CN¥3.99 Billion ≈ $583.66 Million |
CN¥-114.51 Million ≈ $-16.76 Million |
-0.029x | -410.15% |
| 2018-12-31 | CN¥3.77 Billion ≈ $551.75 Million |
CN¥34.90 Million ≈ $5.11 Million |
0.009x | +196.56% |
| 2017-12-31 | CN¥2.48 Billion ≈ $363.53 Million |
CN¥-23.82 Million ≈ $-3.49 Million |
-0.010x | -110.28% |
| 2016-12-31 | CN¥2.13 Billion ≈ $312.01 Million |
CN¥198.76 Million ≈ $29.08 Million |
0.093x | +20.98% |
| 2015-12-31 | CN¥1.91 Billion ≈ $279.22 Million |
CN¥147.02 Million ≈ $21.51 Million |
0.077x | -41.59% |
| 2014-12-31 | CN¥923.93 Million ≈ $135.20 Million |
CN¥121.88 Million ≈ $17.84 Million |
0.132x | +25.34% |
| 2013-12-31 | CN¥846.62 Million ≈ $123.89 Million |
CN¥89.11 Million ≈ $13.04 Million |
0.105x | -14.35% |
| 2012-12-31 | CN¥751.60 Million ≈ $109.98 Million |
CN¥92.36 Million ≈ $13.52 Million |
0.123x | -60.41% |
| 2011-12-31 | CN¥262.67 Million ≈ $38.44 Million |
CN¥81.53 Million ≈ $11.93 Million |
0.310x | +147.44% |
| 2010-12-31 | CN¥197.44 Million ≈ $28.89 Million |
CN¥24.77 Million ≈ $3.62 Million |
0.125x | -60.23% |
| 2009-12-31 | CN¥164.49 Million ≈ $24.07 Million |
CN¥51.88 Million ≈ $7.59 Million |
0.315x | -- |
About China Resources Boya Bio pharmaceutical Group Co Ltd
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII. The company also provides compound b… Read more